EyePoint, Inc. (EYPT)
3.25
+0.02
(+0.62%)
USD |
NASDAQ |
Oct 02, 16:00
3.25
0.00 (0.00%)
After-Hours: 20:00
EyePoint EPS Diluted (Quarterly) : -1.092 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.092 |
| March 31, 2026 | -0.9864 |
| December 31, 2025 | -0.8143 |
| September 30, 2025 | -0.8513 |
| June 30, 2025 | -0.8498 |
| March 31, 2025 | -0.6478 |
| December 31, 2024 | -0.6413 |
| September 30, 2024 | -0.5392 |
| June 30, 2024 | -0.5794 |
| March 31, 2024 | -0.5534 |
| December 31, 2023 | -0.3344 |
| September 30, 2023 | -0.3289 |
| June 30, 2023 | -0.61 |
| March 31, 2023 | -0.5646 |
| December 31, 2022 | -1.163 |
| September 30, 2022 | -0.4933 |
| June 30, 2022 | -0.52 |
| March 31, 2022 | -0.5631 |
| December 31, 2021 | -0.5942 |
| September 30, 2021 | -0.5804 |
| June 30, 2021 | -0.3482 |
| March 31, 2021 | -0.4965 |
| December 31, 2020 | -1.067 |
| September 30, 2020 | -0.2971 |
| June 30, 2020 | -1.038 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.140 |
| December 31, 2019 | -0.9758 |
| September 30, 2019 | -1.463 |
| June 30, 2019 | -1.082 |
| March 31, 2019 | -2.016 |
| December 31, 2018 | -1.20 |
| September 30, 2018 | -4.40 |
| June 30, 2018 | -6.20 |
| March 31, 2018 | -1.50 |
| June 30, 2017 | -1.60 |
| March 31, 2017 | -1.50 |
| December 31, 2016 | -0.0196 |
| September 30, 2016 | -2.10 |
| June 30, 2016 | -1.90 |
| March 31, 2016 | -1.50 |
| December 31, 2015 | -1.80 |
| September 30, 2015 | -1.70 |
| June 30, 2015 | -1.70 |
| March 31, 2015 | -1.70 |
| December 31, 2014 | -1.40 |
| September 30, 2014 | 6.70 |
| June 30, 2014 | -1.40 |
| March 31, 2014 | -0.80 |
| December 31, 2013 | -1.30 |
| September 30, 2013 | -1.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.3501 |
| Eli Lilly & Co. | 7.939 |
| Elanco Animal Health, Inc. | 0.1067 |
| Amylyx Pharmaceuticals, Inc. | -0.3905 |
| Nuvation Bio, Inc. | -0.1802 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -94.47M |
| Revenue (Quarterly) | 0.507M |
| Total Expenses (Quarterly) | 94.98M |
| Enterprise Value | 118.09M |
| Gross Profit Margin (Quarterly) | -36.09% |
| Profit Margin (Quarterly) | -18.63K% |
| Earnings Yield | -115.2% |
| Normalized Earnings Yield | -115.19 |